For the better part of the last decade, the diminishing role of the pharmaceutical sales representative as an integral part of the pharmaceutical sales model has been a hot topic. In the last six months, news of sales reps being banned from a large, acute-care hospital system made industry waves. A week later, pharma sales reps were under attack in Australia when a group of physicians banded together to start a “No Advertising Please” campaign designed to keep reps out. Read
In April 1969 Medical Marketing & Media published the results of an exclusive Detailing & Physician Survey, from which its editors concluded the following: The role of the pharmaceutical “detailman” will remain relevant, despite analysts’ contentions that computer machines may someday replace systems of distribution and dissemination. Read . . .